DDPH对低氧内皮细胞条件培养液诱导肺动脉平滑肌细胞增殖及α-SM-actin表达的影响

目的探讨1-(2,6-二甲基苯氧基)-2-(3,4-二甲氧基苯乙氨基)丙烷盐酸盐(DDPH)抑制低氧内皮细胞条件培养液(HECCM)诱导肺动脉平滑肌细胞增殖及对α-SM-actin表达的影响.方法利用低氧内皮细胞条件培养液建立猪肺动脉平滑肌细胞(PASMC)的增殖模型;以四甲基偶氮唑盐(MTT)比色法、α平滑肌肌动蛋白(α-SM-actin)为指标,采用免疫细胞化学染色法观察低氧内皮细胞条件培养液对肺动脉平滑肌细胞增殖的影响以及DDPH对低氧内皮细胞条件培养液促肺动脉平滑肌细胞增殖后的逆转效应.结果低氧内皮细胞条件培养液显著促进肺动脉平滑肌细胞增殖,低氧内皮细胞条件培养液促肺动脉平滑肌细胞增殖后,肺动脉平滑肌细胞的表型发生转化,由收缩表型转化为合成表型,肺动脉平滑肌细胞胞浆内的α-SM-actin含量下降;DDPH能显著抑制低氧内皮细胞条件培养液对肺动脉平滑肌细胞的增殖作用,并使肺动脉平滑肌细胞的表型发生逆转,即由合成表型逆转为具有执行正常收缩功能的收缩表型,肺动脉平滑肌细胞胞浆内的α-SM-actin含量回升.结论提示DDPH能显著抑制低氧内皮细胞条件培养液促肺动脉平滑肌细胞的增殖作用,其作用机制可能是通过肺动脉平滑肌细胞的表型发生逆转来实现的.     

Fractalkine对大鼠肺动脉平滑肌细胞增殖的影响

目的：观察fractalkine（FKN）对体外培养的大鼠肺动脉平滑肌细胞（PASMCs）增殖的影响。方法：体外培养大鼠PASMCs,加入不同浓度（10-^10、10-^9和10-^8 mol／L）的FKN处理12h、24h和48h,采用四唑盐（MTT）法检测细胞增殖,流式细胞术（FCM）检测细胞周期。结果：MTT试验显示FKN显著促进大鼠PASMCs增殖,此作用呈浓度依赖性。FCM分析显示FKN使S期细胞比例和增殖指数P1值增加。FKN处理PASMCs 12h后,其S期细胞比例和H值即出现增加,24h达高峰。结论：FKN呈浓度依赖方式促进大鼠PASMCs增殖。     

氯化钴对原代大鼠肺动脉成纤维细胞的影响

目的:探究氯化钴对于原代大鼠肺动脉成纤维细胞(PAF)的增殖、迁移、表型转化作用的影响。方法:分离培养大鼠肺动脉成纤维细胞,利用氯化钴刺激PAF细胞,并通过MTT、细胞划痕、Transwell、表型转化标志蛋白测定以及PI3K/Akt信号通路蛋白的变化研究氯化钴对PAF的影响。结果:MTT结果显示,与对照组相比,氯化钴可以抑制大鼠肺动脉成纤维细胞的增殖活性(P0.001),并呈浓度依赖性。划痕实验及Transwell实验提示较高氯化钴(200μmol·L~(-1))处理PAF细胞后可以抑制细胞迁移。随浓度增加,氯化钴可以抑制PAF的P110α、p-Akt蛋白表达。结论:氯化钴对于体外培养的原代大鼠肺动脉成纤维细胞的增殖、迁移和表型转化特性有一定的抑制作用,这可能与氯化钴抑制PI3K/Akt信号通路的表达有关。     

培养的血管平滑肌细胞ERα和ERβ的表达与细胞表型转变及增殖时相有关

目的探讨雌激素对血管平滑肌细胞（VSMC）增殖的双重效应机制。方法采用Westernblot、电镜形态定量及细胞计数的方法,动态检测原代培养大鼠VSMC在有或无10^-8mol/L17β-雌二醇（E2）存在下,雌激素受体（ER）α和β表达变化与细胞表型转变及增殖时相的关系。结果无E2存在时,VSMC在从收缩型向合成型转变（原代培养第0到5天）及活跃增殖（第5到12天）过程中,ERβ表达无明显变化,但ERα表达明显上升,导致ERα/ERβ比值升高。这种变化并不随VSMC表型的恢复及增殖停止而逆转。有E2存在时,ERα/ERβ比值在第5天时低于对照组,而第9天后各时点均高于对照组;这种影响与E2对不同状态VSMC的不同作用基本对应,即延长原代收缩型SMC的增殖潜伏期,但促进已发生表型转变的VSMC增殖。结论雌激素对不同表型VSMC的双重效应与表型转变前后ERα/ERβ比值变化有关。     

内质网应激促进肺动脉平滑肌细胞的表型转化

目的:探讨内质网应激(ERS)对肺动脉平滑肌细胞表型转化的影响。方法:采用胶原酶Ⅰ消化法培养原代大鼠肺动脉平滑肌细胞(PASMCs),用衣霉素(TM)或4-苯基丁酸(4-PBA)诱导或抑制内ERS,MTS法评价细胞增殖情况,western blot和定量RT-PCR检测蛋白和mRNA表达情况。结果:TM呈浓度依赖性诱导内质网应激标志物GRP78和XBP1 mRNA表达;较低浓度的TM促进PASMCs增殖,高浓度(5μg/mol)使细胞凋亡;TM使PASMCs表达SM22 alpha减少,分泌Ⅰ型胶原增加;4-PBA预处理可逆转TM诱导PASMCs的SM22 alpha减少和Ⅰ型胶原分泌增加。结论:内质网应激促进肺动脉平滑肌细胞表型转化,可能是内质网应激参与肺动脉高压的机制之一。     

肾上腺髓质素调节诱导型一氧化氮合酶对缺氧肺动脉平滑肌细胞增殖和凋亡的影响

目的:探讨缺氧对肺动脉平滑肌细胞(PASMC)增殖和凋亡的影响以及诱导型一氧化氮合酶(iNOS)的蛋白表达变化及肾上腺髓质素(ADM)在缺氧影响PASMC增殖和凋亡中的作用与意义.方法:离体缺氧培养大鼠PASMC,采用MTT比色法和PCNA的免疫组化法测定细胞增殖反应,采用流式细胞仪法检测细胞凋亡情况,采用Westen blot蛋白印迹法检测iNOS的蛋白表达.结果:①MTT法发现,缺氧24 h组的A值明显高于常氧组(P＜0.01),而缺氧 ADM组明显低于缺氧组(P＜0.01),与常氧组比较差别无显著性(P＞0.05),缺氧 L-NAME组A值明显高于缺氧组和常氧组(P＜0.01).②免疫组化法发现,常氧组PCNA呈弱阳性表达,而缺氧24 h组PCNA呈阳性表达(P＜0.01).ADM明显抑制了缺氧24 h组PCNA的表达(P＜0.01);而L-NAME则促进了缺氧24 h组PCNA的表达(P＜0.01).③流式细胞仪分析发现,常氧组、缺氧组、缺氧 ADM组、缺氧 L-NAME组,在缺氧培养24 h后,其凋亡指数比较差别无显著性(P均＞0.05).④Westen blot发现常氧组大鼠PASMC见少量iNOS表达,缺氧4 h后,表达明显增多(P＜0.01),8h,24 h持续高表达(P＜0.01);L-NAME对iNOS蛋白的表达没有影响.ADM促进iNOS蛋白的表达.结论:①缺氧能促进肺动脉平滑肌细胞低氧性增殖,对肺动脉平滑肌细胞的凋亡无影响.②缺氧能诱导肺动脉平滑肌细胞表达iNOS,ADM能促进iNOS的表达,ADM、iNOS在HPH发展中可能起到抑制作用.     

NO在CCK—8减轻肿瘤坏死因子诱导兔肺动脉反应性变化中的作用

为探讨八肽胆囊收缩素（CCK－8）缓解内毒素休克时肺动脉高压的作用机制,应用离体血管环张力测定技术及一氧化氮合酶（NOS）检测方法,观察了一氧化氮（NO）在CCK－8减轻肿瘤坏死因子－α（tumor necrosis factor-al-pha,TNF-α）的抑制肺动脉内皮依赖性舒张反应中的作用。结果显示：TNF－α（4000U／ml）孵育2h时,肺动脉对10^-6mol/L苯肾上腺素(phenylephrine,PE）和10^-6mol/L乙酰胆碱（ACh）的收缩反应及内皮依赖性舒张反应均无明显变化。TNF－α孵育7或14h时,肺动脉对10^-6mol/L ACh介导的内皮依赖性舒张反应降低,CCK－8（0.5μg/ml）可逆转TNF－α的上述作用,CCK－8本身对正常肺动脉反应性无明显影响。TNF－α、CCK－8对PE引起的收缩反应无显著影响。L－精氨酸（L－Arg）可使TNF－α7h内皮依赖性舒张作用恢复。氨基胍（AG）不影响各组肺动脉对10^-6mol/L ACh的内皮依赖性舒张反应,而使TNF－α组肺动脉环对10^-6mol/L PE的收缩反应显著增加。L－硝基精氨酸（L－NNA）使各组肺动脉环对10^-6mol/L ACh反应由舒张变为收缩,对10^-6mol/L PE的收缩反应显著增强。检测7h各组NOS活性,TNF－α组、TNF－α＋CCK－8组均较对照组显著增加,CCK－8组与对照组比较无显著差异。上述结果提示,CCK－8可逆转TNF－α对内皮依赖性舒张反应的抑制作用,此作用可能与NO有关。     

大鼠肺动脉平滑肌细胞钙激活氯通道电流的电生理检测

目的：研究大鼠肺动脉平滑肌细胞钙激活氯通道电流的电生理特性。方法：膜片钳全细胞和膜内向外记录模式检测大鼠肺动脉平滑肌细胞上钙激活氯通道全细胞电流和单通道电流。结果：大鼠肺动脉平滑肌细胞记录到稳定的钙激活氯通道电流（ICl（Ca））;ICl（Ca）表现出典型的外向整流特性和电压时间依赖性激活。结论：大鼠肺动脉平滑肌细胞膜上存在电压、时间依赖性氯通道电流,钙激活氯通道通过促进肺动脉平滑肌细胞去极化而成为调节肺动脉特性的关键调节因子。     

成纤维细胞生长因子9抑制PDGF-BB诱导的肺血管平滑肌细胞表型转化

该研究探讨了成纤维细胞生长因子9(fibroblast growth factor 9,FGF9)在肺动脉高压(pulmonary arterial hypertension,PAH)及肺血管平滑肌细胞表型转化中的作用。建立野百合碱(monocrotaline,MCT)诱导的大鼠肺动脉高压模型,Western blot检测大鼠肺组织中FGF9的表达情况。血小板衍生生长因子-BB(platelet-derived growth factor BB,PDGF-BB)诱导肺动脉平滑肌细胞(pulmonary artery smooth muscle cells,PASMCs)表型转化,Western blot检测PASMCs中FGF9的表达情况。重组人成纤维细胞生长因子9(recombinant human fibroblast growth factor 9,rhFGF9)干预PASMCs,通过划痕实验检测细胞迁移能力,Western blot检测细胞表型相关蛋白[α-平滑肌肌动蛋白(α-smooth muscle actin,α-SMA)、骨桥蛋白(osteopontin,OPN)]、增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)及血小板衍生生长因子受体β(platelet-derived growth factor receptor β,PDGFR-β)的表达水平。siRNA抑制FGF9后,Western blot检测PASMCs表型与PCNA蛋白水平。结果显示,大鼠肺组织及PASMCs中FGF9的表达显著降低(P0.05);PDGF-BB下调PDGFR-β与收缩表型标志物α-SMA的表达(P0.05),同时上调PCNA与合成表型标志物OPN的表达(P0.05),且细胞的迁移能力增加;rhFGF9抑制PDGF-BB诱导的细胞表型转化和细胞迁移,而不影响PCNA与PDGFR-β的表达;下调FGF9可降低α-SMA(P0.05)的表达,而PCNA与OPN的表达无显著改变,即下调FGF9后,平滑肌细胞的收缩表型发生改变。总之,rhFGF9抑制PDGF-BB诱导的平滑肌细胞表型转化和迁移,下调FGF9能改变平滑肌细胞的收缩表型,提示FGF9可能参与肺动脉高压的病理过程。     

表皮生长因子对离体大鼠肺动脉及肺动脉平滑肌细胞作用的研究

本研究着重探讨表皮生长因子（ＥＧＦ）对大鼠肺动脉的收缩作用及对肺动脉平滑肌细胞分裂增殖的影响。浓度为１×１０－９－１×１０－７ｍｏｌ／Ｌ的ＥＧＦ可引起大鼠肺动脉剂量依赖性收缩（ｒ＝０．９６８,Ｐ＜０,００１）,其Ｅｍａｘ为１００．６ｍｇ,ＥＣ５０为１１．９６ｎｍｏｌ／Ｌ。在同时存在０．５％胎牛血清（ＦＣＳ）时,ＥＧＦ能促进平滑肌细胞的３Ｈ－ＴｄＲ参入率,该作用与剂量呈正相关（ｒ＝０．８２３,Ｐ＜０．０５）,其ＥＣ５０为６．５×１Ｏ－１２ｍｏｌ／Ｌ。１×１０－９ｍｏｌ／Ｌ的ＥＧＦ＋０．５％ＦＣＳ能产生与１０％ＦＣＳ相当的促细胞分裂增殖能力（在培养的第１,３,５,７天,二者促分裂增殖能力相差不明显,Ｐ均＞０．０５,第９天时,前者大于后者,Ｐ＜０．０５）。１×１０－９ｍｏｌ／ＬＥＧＦ单独存在时对平滑肌细胞未显示出明显的致分裂活性。上述作用提示ＥＣＦ在某些肺血管病变如缺氧性肺动脉高压中可能有一定意义。     

低氧对肺动脉内皮细胞PDGF—B链释放及平滑肌细胞生长的影响

应用蛋白ｄｏｔｂｌｏｔ技术检测了低氧内皮细胞条件培养液（ＨＥＣＣＭ）和常氧内皮细胞条件培养液（ＮＥＣＣＭ）内ＰＤＧＦ相对含量,并利用［３Ｈ］－ＴｄＲ掺入法和流式细胞术观察了ＨＥＣＣＭ和ＮＥＣＣＭ及加入特异ＰＤＧＦ抗体对肺动脉平滑肌细胞（ＰＡＳＭＣ）生长的影响。结果表明,ＨＥＣＣＭ中的ＰＤＧＦ含量明显高于ＮＥＣＣＭ;ＨＥＣＣＭ能明显增强ＰＡＳＭＣ内ＤＮＡ合成,促进ＰＡＳＭＣ从Ｇｏ／Ｇ１期进入Ｓ期;当预先加入ＰＤＧＦ－Ｂ链抗体时,则会明显地抑制ＨＥＣＣＭ对ＰＡＳＭＣ的ＤＮＡ合成,阻止ＰＡＳＭＣ从Ｇｏ／Ｇ１期进入Ｓ期。结果提示,低氧时ＰＡＳＭＣ增殖与肺动脉内皮细胞分泌释放ＰＤＧＦ增加有关     

缺氧对体外培养的肺动脉平滑肌细胞形态及增殖的影响

本实验应用形态学、免疫组化染色,＾３Ｈ－ＴｄＲ掺入、流式细胞等技术探讨缺氧（〈１％Ｏ２和２．５％Ｏ２）对肺动脉平滑肌细胞（ＰＡＳＭ）形态及增殖的影响。结果表明：缺氧２４ｈ使ＰＡＳＭ表型从收缩型向合成型转换,胞浆内ＳＭ－ａ ａｃｔｉｎ减少,线粒体和粗面内质网增多,缺氧４８ｈ以后线粒体肿胀,空泡化,内质网扩张,胞浆内出现髓鞘样结构。流式细胞分析显示缺氧ＰＡＳＭ Ｇ２／Ｍ期细胞比例明显增多（Ｐ〈０．００     

LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension

Pulmonary hypertension (PH) is characterized by a thickening of the distal pulmonary arteries caused by medial hypertrophy, intimal proliferation and vascular fibrosis. Low density lipoprotein receptor-related protein 1 (LRP1) maintains vascular homeostasis by mediating endocytosis of numerous ligands and by initiating and regulating signaling pathways.Here, we demonstrate the increased levels of LRP1 protein in the lungs of idiopathic pulmonary arterial hypertension (IPAH) patients, hypoxia-exposed mice, and monocrotaline-treated rats. Platelet-derived growth factor (PDGF)-BB upregulated LRP1 expression in pulmonary artery smooth muscle cells (PASMC). This effect was reversed by the PDGF-BB neutralizing antibody or the PDGF receptor antagonist. Depletion of LRP1 decreased proliferation of donor and IPAH PASMC in a β1-integrin-dependent manner. Furthermore, LRP1 silencing attenuated the expression of fibronectin and collagen I and increased the levels of α-smooth muscle actin and myocardin in donor, but not in IPAH, PASMC. In addition, smooth muscle cell (SMC)-specific LRP1 knockout augmented α-SMA expression in pulmonary vessels and reduced SMC proliferation in 3D ex vivo murine lung tissue cultures.In conclusion, our results indicate that LRP1 promotes the dedifferentiation of PASMC from a contractile to a synthetic phenotype thus suggesting its contribution to vascular remodeling in PH.     

缺氧对新生小牛肺血管平滑肌细胞增殖的影响及764—3的抑制作用

本研究应用细胞培养、~3H—TdR参入技术,探讨缺氧对新生小牛肺血管平滑肌细胞(PASMC)DNA合成和细胞增殖的影响及746—3和川芎嗪抗细胞增殖效果。结果表明:缺氧的肺血管内皮细胞(PAEC)培养液可以明显增加PASMC中~3H—TdR的参入;缺氧24h亦可直接刺激PASMC,使其中~3H—TdR的参入显著增加(P<0.001);在缺氧的PASMC培养基中加入764—3,~3H—TdR参入值与单纯缺氧组相比显著下降,并使细胞数减少36.3％,764—3还可以显著抑制常氧PASMC的增殖;川芎嗪的作用较小。实验结果提示,缺氧不仅可以刺激内皮细胞(EC)产生促分裂素使PASMC增殖,而且还可以直接刺激PASMC的增殖,764—3可抑制缺氧及血清刺激的PASMC的增殖。     

低氧对肺内小动脉平滑肌细胞血管紧张素转化酶活性和基因表达的影响

实验采用分离培养兔肺内小动脉平滑细胞,观察低氧对ＰＡＳＭＣ的血管紧张素转化酶活性和基因表达的影响。     

脂多糖对离体培养大鼠血管平滑肌细胞增殖的影响

本研究观察到１０－７～１０－５ｋｇ／Ｌ脂多糖（ｌｉｐｏｐｏｌｙｓａｃｈａｒｉｄｅ,ＬＰＳ）可显著促进血管平滑肌细胞（ＶＳＭＣ）的增殖及ＤＮＡ的合成（Ｐ＜００５）。５×１０－４～１０－３ｋｇ／ＬＬＰＳ却抑制ＶＳＭＣ的增殖及ＤＮＡ的合成,降低其活力（Ｐ＜００１）,并呈时间依赖效应。一氧化氮合酶抑制剂ＮＮｉｔｒｏＬＡｒｇｉｎｉｎｅ（ＬＮＮＡ）可拮抗ＬＰＳ的抑制作用。大剂量ＬＰＳ作用组ＶＳＭＣ上清液中一氧化氮（ＮＯ）代谢产物ＮＯ－３和ＮＯ－２的含量与对照组相比显著增加（Ｐ＜００１）,４８ｈ组比２４ｈ组增加９１％,７２ｈ组比４８ｈ组增加４５％;同时,诱导性一氧化氮合酶（ｉｎｄｕｃｔｉｖｅｎｉｔｒｉｃｏｘｉｄｅｓｙｎｔｈａｓｅ,ｉＮＯＳ）免疫组化染色呈阳性。结果表明,低浓度ＬＰＳ促进ＶＳＭＣ增殖和ＤＮＡ合成,而高浓度ＬＰＳ却明显抑制ＶＳＭＣ增殖和ＤＮＡ合成,降低其活力。这种抑制作用可能与ＬＰＳ诱导ＶＳＭＣ产生的ＮＯ有关。     

Over-expression of PKGIα inhibits hypoxia-induced proliferation, Akt activation, and phenotype modulation of human PASMCs: the role of phenotype modulation of PASMCs in pulmonary vascular remodeling

The proliferation of pulmonary artery smooth muscle cells (PASMCs) plays a role in pulmonary vascular remodeling (PVR). Recently, it was shown that vascular smooth muscular cell phenotype modulation is important for their proliferation in other diseases. However, little is known about the role of human PASMC phenotype modulation in the proliferation induced by hypoxia and its molecular mechanism during PVR. In this study, we found using primary cultured human PASMCs that hypoxia suppressed the expression of endogenous PKGIα, which was reversed by transfection with a recombinant adenovirus containing the full-length cDNA of PKGIα (Ad-PKGIα). Ad-PKGIα transfection significantly attenuated the hypoxia-induced downregulation of the expression of smooth muscle α-actin (SM-α-actin), myosin heavy chain (MHC) and calponin in PASMCs, indicating that hypoxia-induced phenotype modulation was blocked. Furthermore, flow cytometry and ³H-TdR incorporation demonstrated that hypoxia-induced PASMC proliferation was suppressed by upregulation of PKGIα. These results suggest that enhanced PKGIα expression inhibited hypoxia-induced PASMC phenotype modulation and that it could reverse the proliferation of PASMCs significantly. Moreover, our previous work has demonstrated that Akt protein is activated in the process of hypoxia-induced proliferation of human PASMCs. Interestingly, we found that Akt was not activated by hypoxia when PASMC phenotype modulation was blocked by Ad-PKGIα. This result suggests that blocking phenotype modulation might be a key up-stream regulatory target.     

ET－1，NO和缺氧对肺动脉平滑肌细胞钙内流及胶原合成的影响

肺血管平滑肌细胞是肺血管收缩反应的主要执行者,也是肺血管结构重建的重要参与者。本研究观察了内皮素１（ＥＴ１）,一氧化氮（ＮＯ）和缺氧对培养的新生小牛肺动肺平滑肌细胞（ＰＡＳＭＣ）钙内流以及胶原合成的影响。结果表明ＥＴ１和缺氧可促进ＰＡＳＭＣ的钙内流,ＮＯ供应剂硝普钠（ＳＭＰ）可抑制ＥＴＩ诱导的钙内流,其作用呈剂量依赖性,ＳＮＰ还可以剂量依赖地抑制ＰＡＳＭＣ的胶原合成,而缺氧可促进ＰＡＳＭＣ的胶原合成。     

MicroRNA-30c contributes to the development of hypoxia pulmonary hypertension by inhibiting platelet-derived growth factor receptor β expression

Pulmonary arterial hypertension (PAH) is characterized by excessive proliferation and resistance to apoptosis of pulmonary artery smooth muscle cells (PASMCs). MicroRNAs have been implicated in the regulation of cell proliferation and might be implicated in the etiology of PAH. Data from in vivo and in vitro cell culture models showed that hypoxia inhibits microRNA-30c (miR-30c) expression in PASMCs. Inhibition of miR-30c by either hypoxia or AMO-30c results in PASMC proliferation (cell viability, 5-bromo-2-deoxyuridine (BrdU) incorporation, proliferating cell nuclear antigen, Ki67, and tubulin polymerization) and the inhibition of apoptosis (cell cycle progression, Cyclin A and Cyclin D, and TUNEL staining). Moreover, down-regulation of miR-30c also results in the phenotype switch from contractile to synthetic PASMC (SM22α and Calponin, osteopontin expression, and wound healing assay). In contrast, these effects were reversed by the application of an miR-30c mimetic under hypoxic conditions. Mechanically, miR-30c inhibited the platelet-derived growth factor receptor β (PDGFRβ) expression by directly binding to the 3′ untranslated region of PDGFRβ mRNA (luciferase reporter assays, and PDGFRβ-masking antisense oligodeoxynucleotides). Pharmacological inhibition of PDGFR by AG-1296 displayed similar effects to the miR-30c mimetic. These data suggest that the down-regulation of miR-30c accounts for the up-regulation of PDGFRβ expression, and subsequent activation of PDGF signaling results in the hypoxia-induced PASMC proliferation and phenotype switching. Therefore, increasing miR-30c expression levels could be explored as a potential new therapy for hypoxia-induced PAH.